ColdZyme

The Science Behind ColdZyme – Insights from Professors
A study with athletes has shown that Enzymatica's oral spray, ColdZyme, significantly shortens the duration of upper respiratory tract infections...

Enzymatica gears up for global expansion after strong first quarter
During the first quarter, Enzymatica increased net sales by 30,3...

Enzymatica's results are published in The Journal of Physiology
Study results show that Enzymatica's ColdZyme mouth spray reduces the amount of virus...

Increased revenue in Q4 but potential for better partner sales for Enzymatica
The cold season is underway and it is also visible in...

Enzymatica is recruiting an experienced marketing manager
Enzymatica strengthens its growth strategy by recruiting Anna...

Enzymatica provides answers to questions
SBU has recently published an evaluation that points...

Final study results: ColdZyme shortens illness duration and relieves symptoms
An independent study at the University of Kent shows...

Strengthened cash flow and adjusted business model will get Enzymatica back on track
After the record numbers before the pandemic, things have gotten even...

Enzymatica's CEO comments on business development and issue
Today marks the start of the subscription period for Enzymatica's rights issue, which will...

MDR certification was Enzymatica's highlight during Q1
Enzymatica has recently published its Q1 report, where they highlight...

Enzymatica comments on the MDR certification for ColdZyme
Enzymatica has received CE certification for ColdZyme according to MDR,...

Enzymatica prepares for expansion through issuance
Enzymatica is working to establish itself on the...
Notes
Mentice consolidates operations to Denver
Bio-Works secures million-dollar order from global pharmaceutical company
OncoZenge receives investment proceeds from Yangtian Bio-Pharmaceutical
Xspray Pharma confirms bioequivalence for XS003
Evaxion converts debt of EUR 3,5 million
NEWSLETTER
NEWS
AI-designed proteins are created in seconds
The price of Leqembi needs to be lowered in Japan
Merck gears up in lung diseases with giant acquisition
Upcoming events!
Investing in Life Science
Discover unparalleled opportunities, set in the vibrant heart of Stockholm. This premier event unites forward-thinking investors and business leaders to...
Life Science Summit
The Nordic region's leading forum for early-stage and growth-phase life science companies. The Summit bridges innovation and capital by providing...
You deserve the best!
Unlock our premium content: Become a subscriber!
Create Account
Chronicles

The market is taking Trump's tariff threat in stride

The EU's new life science strategy – a step in the right direction or just fluff?
